tiprankstipranks
Trending News
More News >
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (HK:1276)
:1276
Hong Kong Market

Compare Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (1276) vs. Competitors

Compare
3 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H
HK$76.75
HK$471.21B
66.03
39.17%
3 Buy
1 Hold
1 Sell
Moderate Buy
CSPC Pharmaceutical Group
$0.96
$13.55B
20.73
69.49%
12 Buy
1 Hold
3 Sell
Moderate Buy
Wuxi Biologics (Cayman)
$4.30
$19.65B
30.05
116.62%
2 Buy
1 Hold
0 Sell
Moderate Buy
WuXi AppTec Co., Ltd. Class H
HK$98.70
HK$323.45B
19.96
111.56%
9 Buy
1 Hold
0 Sell
Strong Buy
Hansoh Pharmaceutical Group Company Limited
HK$41.60
HK$251.89B
47.92
152.43%
5 Buy
1 Hold
0 Sell
Strong Buy
BeiGene Ltd
HK$184.50
HK$321.99B
634.41
79.20%
14 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:1276
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H
76.75
23.05
42.92%
CHJTF
CSPC Pharmaceutical Group
0.96
0.42
77.96%
WXIBF
Wuxi Biologics (Cayman)
4.30
2.06
91.96%
HK:2359
WuXi AppTec Co., Ltd. Class H
111.60
60.93
120.25%
HK:3692
Hansoh Pharmaceutical Group Company Limited
41.60
25.52
158.71%
HK:6160
BeiGene Ltd
197.30
90.70
85.08%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts